Systemic effects of treatment with mTOR inhibitors in tuberous sclerosis complex: a comprehensive review
Published 2015 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Systemic effects of treatment with mTOR inhibitors in tuberous sclerosis complex: a comprehensive review
Authors
Keywords
-
Journal
JOURNAL OF THE EUROPEAN ACADEMY OF DERMATOLOGY AND VENEREOLOGY
Volume 30, Issue 4, Pages 586-594
Publisher
Wiley
Online
2015-09-25
DOI
10.1111/jdv.13356
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Use of mTOR Inhibitor Everolimus in Three Neonates for Treatment of Tumors Associated With Tuberous Sclerosis Complex
- (2015) Isabelle Goyer et al. PEDIATRIC NEUROLOGY
- Congenital subependymal giant cell astrocytomas in patients with tuberous sclerosis complex
- (2014) Katarzyna Kotulska et al. CHILDS NERVOUS SYSTEM
- Mammalian Target of Rapamycin Inhibitors for Intractable Epilepsy and Subependymal Giant Cell Astrocytomas in Tuberous Sclerosis Complex
- (2014) Michael Cardamone et al. JOURNAL OF PEDIATRICS
- Everolimus for subependymal giant cell astrocytoma in patients with tuberous sclerosis complex: 2-year open-label extension of the randomised EXIST-1 study
- (2014) David Neal Franz et al. LANCET ONCOLOGY
- The effect of everolimus on renal angiomyolipoma in patients with tuberous sclerosis complex being treated for subependymal giant cell astrocytoma: subgroup results from the randomized, placebo-controlled, Phase 3 trial EXIST-1
- (2014) J. C. Kingswood et al. NEPHROLOGY DIALYSIS TRANSPLANTATION
- Everolimus in Immunosuppressive Treatment After Kidney Transplantation in a Patient With Tuberous Sclerosis: Case Report
- (2014) A. Tarasewicz et al. TRANSPLANTATION PROCEEDINGS
- Targeting PI3K/Akt/mTOR Signaling in Cancer
- (2014) Camillo Porta et al. Frontiers in Oncology
- Everolimus treatment of refractory epilepsy in tuberous sclerosis complex
- (2013) Darcy A. Krueger et al. ANNALS OF NEUROLOGY
- Successful everolimus therapy for SEGA in pediatric patients with tuberous sclerosis complex
- (2013) A. M. Cappellano et al. CHILDS NERVOUS SYSTEM
- Rapamycin has a beneficial effect on controlling epilepsy in children with tuberous sclerosis complex: results of 7 children from a cohort of 86
- (2013) Mehmet Canpolat et al. CHILDS NERVOUS SYSTEM
- Everolimus in tuberous sclerosis patients with intractable epilepsy: A treatment option?
- (2013) Gert Wiegand et al. EUROPEAN JOURNAL OF PAEDIATRIC NEUROLOGY
- Management of subependymal giant cell astrocytoma (SEGA) associated with tuberous sclerosis complex (TSC): Clinical recommendations
- (2013) Sergiusz Jóźwiak et al. EUROPEAN JOURNAL OF PAEDIATRIC NEUROLOGY
- Long-term effect of everolimus on epilepsy and growth in children under 3 years of age treated for subependymal giant cell astrocytoma associated with tuberous sclerosis complex
- (2013) Katarzyna Kotulska et al. EUROPEAN JOURNAL OF PAEDIATRIC NEUROLOGY
- Everolimus for angiomyolipoma associated with tuberous sclerosis complex or sporadic lymphangioleiomyomatosis (EXIST-2): a multicentre, randomised, double-blind, placebo-controlled trial
- (2013) John J Bissler et al. LANCET
- Tuberous Sclerosis Complex Diagnostic Criteria Update: Recommendations of the 2012 International Tuberous Sclerosis Complex Consensus Conference
- (2013) Hope Northrup et al. PEDIATRIC NEUROLOGY
- Possible Prevention of Tuberous Sclerosis Complex Lesions
- (2013) K. Kotulska et al. PEDIATRICS
- Topical Rapamycin Therapy to Alleviate the Cutaneous Manifestations of Tuberous Sclerosis Complex
- (2013) Mary Kay Koenig et al. Drugs in research & development
- Finding a better drug for epilepsy: The mTOR pathway as an antiepileptogenic target
- (2012) Aristea S. Galanopoulou et al. EPILEPSIA
- Efficacy and safety of everolimus for subependymal giant cell astrocytomas associated with tuberous sclerosis complex (EXIST-1): a multicentre, randomised, placebo-controlled phase 3 trial
- (2012) David Neal Franz et al. LANCET
- Everolimus alters white matter diffusion in tuberous sclerosis complex
- (2012) J.-M. Tillema et al. NEUROLOGY
- Assessing the effectiveness of rapamycin on angiomyolipoma in tuberous sclerosis: a two years trial
- (2012) Cristina Cabrera-López et al. Orphanet Journal of Rare Diseases
- Rapamycin reverses impaired social interaction in mouse models of tuberous sclerosis complex
- (2012) Atsushi Sato et al. Nature Communications
- Treatment of facial angiofibromas with topical application of oral rapamycin solution (1 mg mL−1) in two patients with tuberous sclerosis
- (2011) M.M. Mutizwa et al. BRITISH JOURNAL OF DERMATOLOGY
- Sirolimus Therapy for Angiomyolipoma in Tuberous Sclerosis and Sporadic Lymphangioleiomyomatosis: A Phase 2 Trial
- (2011) D. M. Davies et al. CLINICAL CANCER RESEARCH
- Management of adverse events associated with the use of everolimus in patients with advanced renal cell carcinoma
- (2011) Camillo Porta et al. EUROPEAN JOURNAL OF CANCER
- Effective everolimus treatment of inoperable, life-threatening subependymal giant cell astrocytoma and intractable epilepsy in a patient with tuberous sclerosis complex
- (2011) Marta Perek-Polnik et al. EUROPEAN JOURNAL OF PAEDIATRIC NEUROLOGY
- Sustained clinical effectiveness and favorable safety profile of topical sirolimus for tuberous sclerosis - associated facial angiofibroma
- (2011) R. Salido et al. JOURNAL OF THE EUROPEAN ACADEMY OF DERMATOLOGY AND VENEREOLOGY
- Growth of kidney-transplanted pediatric patients treated with sirolimus
- (2011) David González et al. PEDIATRIC NEPHROLOGY
- Regression of a Cardiac Rhabdomyoma in a Patient Receiving Everolimus
- (2011) D. Tiberio et al. PEDIATRICS
- Multicenter Phase 2 Trial of Sirolimus for Tuberous Sclerosis: Kidney Angiomyolipomas and Other Tumors Regress and VEGF- D Levels Decrease
- (2011) Sandra L. Dabora et al. PLoS One
- Topical Rapamycin
- (2010) Anna K. Haemel et al. ARCHIVES OF DERMATOLOGY
- Everolimus for Subependymal Giant-Cell Astrocytomas in Tuberous Sclerosis
- (2010) Darcy A. Krueger et al. NEW ENGLAND JOURNAL OF MEDICINE
- Rapamycin therapy for renal, brain, and skin lesions in a tuberous sclerosis patient
- (2010) Hasan Micozkadioglu et al. RENAL FAILURE
- Sirolimus in renal transplant recipients with tuberous sclerosis complex: clinical effectiveness and implications for innate immunity
- (2010) Michael Haidinger et al. TRANSPLANT INTERNATIONAL
- Rapamycin as a Therapy of Choice After Renal Transplantation in a Patient With Tuberous Sclerosis Complex
- (2009) A. Tarasewicz et al. TRANSPLANTATION PROCEEDINGS
- Tuberous sclerosis
- (2008) Paolo Curatolo et al. LANCET
- Sirolimus for Angiomyolipoma in Tuberous Sclerosis Complex or Lymphangioleiomyomatosis
- (2008) John J. Bissler et al. NEW ENGLAND JOURNAL OF MEDICINE
- Cardiac rhabdomyoma in tuberous sclerosis: Hyperactive Erk signaling
- (2007) Jaroslaw Jozwiak et al. INTERNATIONAL JOURNAL OF CARDIOLOGY
Find Funding. Review Successful Grants.
Explore over 25,000 new funding opportunities and over 6,000,000 successful grants.
ExploreAdd your recorded webinar
Do you already have a recorded webinar? Grow your audience and get more views by easily listing your recording on Peeref.
Upload Now